Stock IBLHL IBL HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials IBL HealthCare Limited

Equities

IBLHL

PK0095501018

Drug Retailers

End-of-day quote Pakistan S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
34.48 PKR -0.35% Intraday chart for IBL HealthCare Limited -1.09% -4.80%
04-29 IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
04-26 IBL Healthcare Limited Announces CEO Changes CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 4,339 1,812 4,189 6,011 3,374 2,324
Enterprise Value (EV) 1 4,256 1,949 4,348 6,178 3,537 2,526
P/E ratio 29.1 x 14.9 x 19 x 20 x 11.1 x 7.52 x
Yield 1.25% 2.99% 2.58% 0.9% 1.92% -
Capitalization / Revenue 3.19 x 1.14 x 1.57 x 2 x 0.92 x 0.58 x
EV / Revenue 3.13 x 1.23 x 1.63 x 2.06 x 0.97 x 0.63 x
EV / EBITDA 22.6 x 11.6 x 14.3 x 15 x 6.14 x 4.12 x
EV / FCF 1,812 x -6.78 x 53 x 24.1 x 37.3 x 43.6 x
FCF Yield 0.06% -14.7% 1.89% 4.15% 2.68% 2.29%
Price to Book 3.65 x 1.44 x 2.95 x 3.72 x 1.81 x 1.1 x
Nbr of stocks (in thousands) 85,675 85,675 85,675 85,675 85,675 85,675
Reference price 2 50.65 21.15 48.90 70.16 39.39 27.12
Announcement Date 08/10/18 08/10/19 02/10/20 06/10/21 07/10/22 06/10/23
1PKR in Million2PKR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 1,358 1,585 2,665 3,004 3,651 4,028
EBITDA 1 188.5 167.3 303.4 411.8 576 613
EBIT 1 187.3 164.7 299.1 406.8 570.7 609.7
Operating Margin 13.79% 10.39% 11.23% 13.54% 15.63% 15.14%
Earnings before Tax (EBT) 1 212.3 199 321.8 409.1 483.3 458.8
Net income 1 149.3 121.4 220 300.5 302.9 309
Net margin 10.99% 7.66% 8.26% 10% 8.29% 7.67%
EPS 2 1.743 1.417 2.568 3.507 3.535 3.606
Free Cash Flow 1 2.349 -287.3 82.08 256.3 94.93 57.95
FCF margin 0.17% -18.13% 3.08% 8.53% 2.6% 1.44%
FCF Conversion (EBITDA) 1.25% - 27.05% 62.25% 16.48% 9.45%
FCF Conversion (Net income) 1.57% - 37.31% 85.31% 31.35% 18.76%
Dividend per Share 2 0.6313 0.6313 1.263 0.6313 0.7576 -
Announcement Date 08/10/18 08/10/19 02/10/20 06/10/21 07/10/22 06/10/23
1PKR in Million2PKR
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - 137 159 167 163 202
Net Cash position 1 83.5 - - - - -
Leverage (Debt/EBITDA) - 0.8164 x 0.5225 x 0.4058 x 0.2831 x 0.3293 x
Free Cash Flow 1 2.35 -287 82.1 256 94.9 57.9
ROE (net income / shareholders' equity) 13.1% 9.93% 16.4% 19.8% 17.4% 15.6%
ROA (Net income/ Total Assets) 8.62% 6.26% 9.03% 10.8% 13.3% 11.8%
Assets 1 1,733 1,939 2,437 2,777 2,282 2,628
Book Value Per Share 2 13.90 14.70 16.60 18.80 21.70 24.60
Cash Flow per Share 2 0.3200 0.3600 0.2400 1.070 1.220 1.120
Capex 1 4.6 4.03 4.07 4.89 1.3 2.83
Capex / Sales 0.34% 0.25% 0.15% 0.16% 0.04% 0.07%
Announcement Date 08/10/18 08/10/19 02/10/20 06/10/21 07/10/22 06/10/23
1PKR in Million2PKR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Drug Retailers

1st Jan change Capi.
IBL HEALTHCARE LIMITED Stock IBL HealthCare Limited
-4.80% 10.62M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-31.83% 15.68B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-20.59% 12.39B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-21.23% 6.74B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-6.15% 6.29B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+11.76% 6.26B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+70.00% 4.95B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-2.48% 4.66B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-5.58% 4.03B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-7.87% 3.62B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. IBLHL Stock
  4. Financials IBL HealthCare Limited